Pablo Ingelmo
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents. (NCT05213065) | Pablo Ingelmo | 2022-02-05 |
Track Pablo Ingelmo automatically
Every clearance here is in the API, with alerts when new ones post.